Loading clinical trials...
Loading clinical trials...
Scleroderma is a complex connective tissue disease involving three interconnected pathophysiological axes: vascular hyperactivity and remodelling, immune system dysfunction and over-activation of fibr...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Centre Hospitalier Universitaire Dijon
NCT07470151 · System Lupus Erythematosus(SLE), Scleroderma, and more
NCT06801119 · Systemic Lupus Erythematosus, Scleroderma, and more
NCT04402086 · Rheumatic Diseases, Adult Onset Still Disease, and more
NCT07343115 · Systemic Scleroderma
NCT07090226 · Systemic Scleroderma, Diffuse Cutaneous Scleroderma
CHU Dijon Bourgogne
Dijon
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions